Health-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapy.
about
PASI90 response: the new standard in therapeutic efficacy for psoriasis.Adalimumab: A Review in Chronic Plaque Psoriasis.Which is worse in psoriasis - skin or joints?Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption.
P2860
Health-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Health-related quality of life ...... hdrawal of adalimumab therapy.
@ast
Health-related quality of life ...... hdrawal of adalimumab therapy.
@en
type
label
Health-related quality of life ...... hdrawal of adalimumab therapy.
@ast
Health-related quality of life ...... hdrawal of adalimumab therapy.
@en
prefLabel
Health-related quality of life ...... hdrawal of adalimumab therapy.
@ast
Health-related quality of life ...... hdrawal of adalimumab therapy.
@en
P2093
P2860
P1476
Health-related quality of life ...... hdrawal of adalimumab therapy.
@en
P2093
Henrique D Teixeira
Pranav Sheth
Yves Poulin
P2860
P2888
P356
10.1007/S13555-014-0043-4
P577
2014-02-01T00:00:00Z
P5875
P6179
1024139205